Business Standard

Wednesday, December 25, 2024 | 01:01 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

WHO nod for Pfizer Covid vaccine may allow better access to poor nations

Every country that has a drug regulatory agency will have to issue its own approval for any Covid-19 vaccine, but countries with weak systems usually rely on WHO to vet the shots

WHO nod for Pfizer Covid vaccine may allow better access to poor nations
Premium

The BioNTech-Pfizer vaccine has to be stored at ultra-frozen temperatures, a big hurdle for developing countries where the required freezers and reliable electricity supply may not be available.

APPTI Geneva
The World Health Organization says it has cleared the Pfizer-BioNTech coronavirus vaccine for emergency use, meaning poorer countries may soon get access to the shot already available in Europe and North America.

Every country that has a drug regulatory agency will have to issue its own approval for any Covid-19 vaccine, but countries with weak systems usually rely on WHO to vet the shots.

The global body said late Thursday that the decision to issue its first emergency use validation for a Covid-19 vaccine "opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine."

The

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in